Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies

Eduard Vieta; Jamie Mullen; Martin Brecher; Björn Paulsson; Martin Jones

doi:10.1185/030079905x46340

Back

Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies

Article 2005 en

Abstract

1 min read

The data from this combined analysis support the results from the individual studies and indicate that quetiapine monotherapy is effective across a broad range of mood symptoms, fast-acting and well tolerated in the treatment of mania.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2007

A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania

Lakshmi N. Yatham, Eduard Vieta, Allan H. Young, Hans‐Jürgen Möller, Björn Paulsson, Mårten Vågerö

Article2005

Mood stabilization in the treatment of bipolar disorder: focus on quetiapine

Eduard Vieta

Article2008

Quetiapine for the treatment of bipolar II depression: Analysis of data from two randomized, double-blind, placebo-controlled studies

Trisha Suppes, Robert M. A. Hirschfeld, Eduard Vieta, Shane Raines, Björn Paulsson

Article2013

MAINTENANCE TREATMENT WITH QUETIAPINE WHEN COMBINED WITH EITHER LITHIUM OR DIVALPROEX IN BIPOLAR I DISORDER: ANALYSIS OF TWO LARGE RANDOMIZED, PLACEBO-CONTROLLED TRIALS

Trisha Suppes, Eduard Vieta, U. Gustafsson, Birgit Ekholm

Article2007

Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid‐cycling disease course: a randomized, double‐blind, placebo‐controlled study

Eduard Vieta, JR Calabrese, JM Goikolea, Shane Raines, Wayne Macfadden